Search

Your search keyword '"Stein, Mark"' showing total 3,268 results

Search Constraints

Start Over You searched for: Author "Stein, Mark" Remove constraint Author: "Stein, Mark"
3,268 results on '"Stein, Mark"'

Search Results

153. Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)

155. The New Rules of Computer Shopping; What you need to know when buying this vital tool

156. Should You Buy Phone Insurance? What to consider before purchasing

157. Evolving and Implanting Web-Based E-Government-Systems in Universities

161. Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer

167. Toward Precision Medicine in ADHD

168. Abstract CT153: TiTAN: a phase 1 study of GEN-011, a neoantigen-targeted peripheral blood-derived T cell therapy with broad neoantigen targeting

169. EVEREST: Everolimus for renal cancer ensuing surgical therapy—A phase III study (SWOG S0931, NCT01120249).

170. A randomized phase Ib/II study of intermittent androgen deprivation therapy plus nivolumab with or without interleukin-8 blockade in men with hormone-sensitive prostate cancer (MAGIC-8).

171. A phase 2, multicenter, parallel-group, open-label study of vudalimab (XmAb20717), a PD-1 x CTLA-4 bispecific antibody, alone or in combination with chemotherapy or targeted therapy in patients with molecularly defined subtypes of metastatic castration-resistant prostate cancer.

172. A phase I study of ADXS-504, a cancer type specific immunotherapy, for patients with biochemically recurrent prostate cancer.

173. A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3).

175. Single-Cell RNAseq Analysis Reveals Robust, Anti-PD-1-Mediated Increase of Immune Infiltrate in Metastatic Castration-Sensitive Prostate Cancer

178. Symposia

183. Autorinnen und Autoren A–Z

185. Gyms in Europe Aim To Lure Back People After Lockdowns

186. Toward Precision Medicine in ADHD

188. ADHD Treatment with Once-Daily OROS Methylphenidate: Final Results from a Long-term Open-Label Study

192. Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced clear cell renal cell (HCRN GU16-260-Cohort A): Final report.

193. Safety and early efficacy results from a phase 1, multicenter trial of PSMA-targeted armored CAR T cells in patients with advanced mCRPC.

196. Characterizing physical activity in children with ADHD and comparing subjective report to actigraphy

197. Physical Activity, Screen Time, and Sleep in Children With ADHD.

199. Development and SAR of functionally selective allosteric modulators of GABA A receptors

200. Audience Analysis for 'The Making, Shaping and Treating of Steel': A Pilot Study. Final Report Presented to United States Steel and the Association of Iron and Steel Engineers. CDC Technical Report No. 10.

Catalog

Books, media, physical & digital resources